baber/WOPTO huggingface dataset:
Patent NZ-574805-A (NZ)
Title: Hepatitis c virus inhibitors
Inventor: LANGLEY DAVID R
IPC: C07D401/14
Filed: 2007-08-09
Abstract: Disclosed is a bis diazole imidazole substituted biphenyl compound of formula (I) where the substituents are as described in the description. Also disclosed is a pharmaceutical composition comprising a compound of formula (I) and the use of a compound of formula (I) in the manufacture of a medicament for treating HCV infection. Examples of compounds of formula (I) are: methyl ((1S)-1-(((2S)-2-(5-( 4'-(2-((2S)-1-((2S)-2-((methoxycarbonyl)amino)-3-methyIbutanoyl)-2-pyrrolidinyI)-1H-imidazol-5-yl)-4-biphenyIyl)-1H -imidazol-2-yl)1-pyrrolidinyl)carbonyl)-2-methyIpropyI)carbamate; (1R,1'R)-2,2'-(4,4'-biphenyldiylbis(1H-imidazole-5,2-diyl(2S)-2,1-prrrolidinediyI))bis(N,N-dimethyl-2-oxo-1-phenylethanamine) and methyl ((1S)-2-((2S)-2-(5-(4'-(2-((2S)-1-((2R)-2-( diethylamino)-2-phenylacetyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)-4-biphenylyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)-1-methyl-2-oxoethyl)carbamate.
Patent NZ-578434-A (NZ)
Title: Systems and methods for providing gaming activities
Inventor: AMOUR MARC
IPC: A63F3/08
Filed: 2008-09-10
Abstract: Disclosed is a method for providing gaming activities, particularly relating to gaming activities implemented in conjunction with a flexible credit arrangement. In overview, a consumer is allocated one or more entries in a gaming activity based on a level of transactable flexible credit held by that consumer. For example, the allocation of entries is increased or decreased subject to a corresponding increase or decrease in transactable flexible credit held by the consumer. In some embodiments, one or more prizes for the gaming activity are funded in whole, or in part, by way of supplementary contributions realized on the basis of consumers' participation in a flexible credit infrastructure.
Patent NZ-581770-A (NZ)
Title: Facility access integrated with other security systems
Inventor: NEWMAN KURT D
IPC: G08B13/24
Filed: 2009-12-08
Abstract: An apparatus and a method for authorizing access to a restricted area are disclosed. The apparatus comprises a processor and a memory having stored therein computer executable instructions, that when executed by the processor, cause the apparatus to perform a method of identifying an individual seeking access to a restricted area; determining whether the identified individual is authorized to access the restricted area; if authorized, permitting entry of the identified individual into the restricted area; determining a time period of a plurality of time periods to disable an alarm system of the restricted area based on at least one characteristic associated with the identified individual; and disabling the alarm system for the time period.
Patent NZ-586151-A (NZ)
Title: System and apparatus for a high perfomance gigabit passive optical network
Inventor: CHEN DAVID Z
IPC: H04J14/00
Filed: 2008-11-24
Abstract: 586151 Disclosed are systems for a high performance gigabit passive optical network. The systems include an optical network terminal (ONT) or an optical line terminal (OLT) that includes an ONT (or OLT) transmitter. The transmitter includes one or more fixed wavelength optical sources to generate a first optical signal at a first wavelength, and a first optical waveguide to transmit the first optical signal at the first wavelength in an optical network. The systems also include an ONT (or OLT) receiver. The receiver includes a second optical waveguide to receive, from the optical network, a second optical signal at a second wavelength, and one or more fixed wavelength optical filters to receive, from the second optical waveguide, the second optical signal at the second wavelength. Each of the one or more fixed wavelength optical filters includes a plurality of fixed wavelength optical filter elements to receive, from the optical network, a respective plurality of optical signals at a respective plurality of wavelengths. The system also includes a magnetic-based device to move one of the pluralities of fixed wavelength optical filter elements to receive the second optical signal at the second wavelength, and an optical receiver to receive the second optical signal at the second wavelength from the one of the plurality of fixed wavelength optical filter elements moved by the magnetic-based device.
Patent NZ-587021-A (NZ)
Title: Cyclist shoe fitting system and method for assessing a cyclist and modify the forefoot tilt by wedging
Inventor: HOGG STEPHEN JOHN
IPC: A63B69/16
Filed: 2010-07-27
Abstract: A system and method for fitting a cyclist in a cycling shoe is disclosed. The system comprises: a cycling shoe, a testing frame, and at least one wedge. The cycling shoe receives a foot of the cyclist and includes a cleat. The testing frame has a clipless pedal to receive and engage the cleat of the cycling shoe to support the cyclist on the clipless pedal. Whilst the cleated shoe of the cyclist is coupled to the clipless pedal, the cyclist is challenged to resist an external force applied to a part of their body. In response to the cyclist failing the physical challenge, at least one of the wedges is arranged on the cycling shoe to alter the forefoot tilt of the cyclist, and the challenge repeated until the cyclist passes the challenge.
Patent NZ-587853-A (NZ)
Title: Heat exchange device having serpentine or convoluted flow path
Inventor: GILBERT PATRICK
IPC: F28D7/04
Filed: 2009-02-13
Abstract: A heat exchanger device (1) such as for use in recovering heat from shower waste water includes a casing base (2) and lid forming an enclosure containing a first fluid conduit and a second fluid conduit (5). The second conduit is for fresh water supply and located in the first conduit. The second conduit has conduit sections in a serpentine path through the first conduit. The first and second conduits are arranged generally for counter-flow heat exchange with the second conduit having elongate sections configured generally transverse to a flow direction through the first conduit. The first conduit has baffles at an inlet and an outlet thereof for keeping the second conduit submerged in the first conduit. The device is provided with a foot or bodyweight operated actuation valve for actuating fresh water supply through the first conduit.
Patent NZ-597981-A (NZ)
Title: Acylated glucagon analogues
Inventor: RIBER DITTE
IPC: A61K38/26
Filed: 2010-06-24
Abstract: Patent No. 597981 Disclosed is a compound having the formula: R1-Z-R2 wherein R1 is H, C1-4 alkyl, acetyl, formyl, benzoyl or trifluoroacetyl; R2 is OH or NH2; and Z is a peptide having the formula I His-X2-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-X12-Tyr-Leu-Asp-X16-X17-Ala-Ala-X20-X21-Phe- Val-X24-Trp-Leu-X27-X28-Ala-X30; (I) wherein X2 is selected from Aib and Ser; X12 is selected from Lys, Arg or Leu; X16 is selected from Arg and X; X17 is selected from Arg and X; X20 is selected from Arg, His and X; X21 is selected from Asp and Glu; X24 is selected from Ala and X; X27 is selected from Leu and X; X28 is selected from Arg and X; X30 is X or is absent; wherein at least one of X16, X17, X20, X24, X27, X28, and X30 is X; and wherein each residue X is independently selected from the group consisting of Glu, Lys, Ser, Cys, Dbu, Dpr and Orn; wherein the side chain of at least one residue X is conjugated to a lipophilic substituent having the formula: (i) Z1, wherein Z1 is a lipophilic moiety conjugated directly to the side chain of X; or (ii) Z1Z2, wherein Z1 is a lipophilic moiety, Z2 is a spacer, and Z1 is conjugated to the side chain of X via Z2; with the proviso that Z is not HSQGTFTSDYSKYLDS-K(Hexadecanoyl-γ-Glu)-AAHDFVEWLLRA. Also disclosed are the compounds such as HSQGTFTSDYSKYLDSKAAHDFVEWLLRA; HSQGTFTSDYSKYLDKKAAHDFVEWLLRA and HSQGTFTSDYSKYLDSKAAKDFVEWLLRA.
Patent NZ-603222-A (NZ)
Title: Filter additive
Inventor: SAMPSON John
IPC: A24D3/02
Filed: 2011-05-11
Abstract: 603222 Disclosed is a method for making a smoking article filter element comprising sheet filter material and an additive, and a filter element and smoking article made from such a method. The method comprises the steps of: i) applying an additive which is solid at room temperature to the sheet filter material; ii) heating the additive so as to melt it; and iii) forming the sheet filter material and additive into a filter element, wherein the steps of the method may be carried out in any order.
Patent NZ-607004-A (NZ)
Title: Distinguishing closed and open respiratory airway apneas by complex admittance values
Inventor: OATES JOHN DAVID
IPC: A61M16/00
Filed: 2007-08-30
Abstract: 607004 Disclosed is a respiratory apparatus for detecting central apnoea. The respiratory apparatus is comprised of a flow generator (34), a flow sensor (50), a pressure sensor (48) and a controller (62). The flow generator is configured to provide a supply of pressurised gas and adapted to couple with a mask (30) to sealingly engage with a patient’s face. The controller is coupled to the flow sensor and the pressure sensor and configured to control a sinusoidal pressure oscillation at the flow generator. The controller is also configured to calculate the AC component of mask pressure; calculate vent flow and leak flow based on mask pressure; calculate AC components of the vent flow and the leak flow by using Fourier sine and cosine components at the oscillation frequency; calculate AC component of patient airflow based on the AC components of the vent flow and the leak flow; and determine airway admittance based on the AC component of the patient airflow and the AC component of the mask pressure.
Patent NZ-613570-A (NZ)
Title: Internet isolation for avoiding internet security threats
Inventor: HOY ROBERT B
IPC: G06F21/56
Filed: 2012-01-27
Abstract: 613570 A host computer supports a virtual guest system running is disclosed. The host computer has a firewall that prevents it from communicating directly with the Internet, except with predetermined trusted sites. The virtual guest runs on a hypervisor, and the virtual guest comprises primarily a browser program that is allowed to contact the Internet freely via an Internet access connection that is completely separate from the host computer connection, such as a dedicated network termination point with its specific Internet IP address, or by tunneling through the host machine architecture to reach the Internet without exposing the host system. The virtual guest system is separated and completely isolated by an internal firewall from the host, and the guest cannot access any of the resources of the host computer, except that the guest can initiate cut, copy and paste operations that reach the host, and the guest can also request print of documents. The host can transfer files to and from a virtual data storage area accessible by the guest by manual operator action. No other transfer of data except these user initiated actions is permitted.
Patent NZ-614475-A (NZ)
Title: Method and apparatus for imparting an organoleptic quality to a recipient product
Inventor: MCLELLAN ANDREW
IPC: A23L27/10
Filed: 2012-03-06
Abstract: An apparatus for imparting an organoleptic quality such as smell or taste to a recipient product (2) such as tobacco is disclosed. The apparatus uses a sensate substance obtained from a donor product (8), such as mint. The apparatus has a donor product storage chamber (9) and a recipient product storage chamber (1). The apparatus is arranged to allow a fluid to circulate repeatedly between the donor product storage chamber and the recipient product storage chamber so that at least one sensate substance obtained from the donor product is conveyed from the donor product storage chamber into the recipient product storage chamber and into contact with the recipient product. Monitoring and control of the process is also disclosed.
Patent NZ-615539-A (NZ)
Title: Treatment of hepatitis c virus infection with alisporivir
Inventor: AVILA CLAUDIO
IPC: A61P31/14
Filed: 2012-04-11
Abstract: Disclosed is the use of alisporivir in the manufacture of a medicament for the treatment of a Hepatitis C virus genotype 1 infected patient, wherein the medicament is adapted for administration in combination with standard of care; wherein the patient is a relapser; wherein the medicament is adapted for administration of alisporivir during an initial phase in an amount of about 600 mg twice per day, followed by a second phase in an amount of about 600 to about 1000 mg once per day; and wherein the standard of care is a combination of interferon with ribavirin.
Patent NZ-617238-A (NZ)
Title: Combinations of akt inhibitor compounds and abiraterone, and methods of use
Inventor: NANNINI MICHELLE
IPC: C07D239/70
Filed: 2012-03-30
Abstract: Disclosed are combinations of a) a compound of Formula (Ia) 2-(4-chlorophenyl)-3-(isopropylamino)-1-(4-((R)-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)propan-1-one (GDC-0068/ipatasertib) or a pharmaceutically acceptable salt thereof, and b) abiraterone or a pharmaceutically acceptable salt thereof for the prophylactic or therapeutic treatment of a hyperproliferative disorder, such as cancer.
Patent NZ-618134-A (NZ)
Title: Azaadamantane derivatives and their uses as nicotinic acetylcholine receptors ligands
Inventor: SCHRIMPF MICHAEL R
IPC: C07D451/14
Filed: 2007-11-06
Abstract: Disclosed herein are the azaadamantane derivative compounds: (4s)-4-(6-phenylpyridazin-3-yloxy)-1-azatricyclo[3.3.1.13,7]decane; (4r)-4-(6-phenylpyridazin-3-yloxy)-1-azatricyclo[3.3.1.13,7]decane; (4s)-4-(5-phenylpyridin-2-yloxy)-1-azatricyclo[3.3.1.13,7]decane; (4r)-4-(5-phenylpyridin-2-yloxy)-1-azatricyclo[3.3.1.13,7]decane; 5-[2-(1-azatricyclo[3.3.1.13,7]decan-(4s)-yloxy)thiazol-5-yl]-indolin-2-one; 5-[2-(1-azatricyclo[3.3.1.13,7]decan-1-oxide-(4s)-yloxy)thiazol-5-yl]-indolin-2-one; (4s)-4-(5-phenoxy-1,3,4-thiadiazol-2-yloxy)-1-azatricyclo[3.3.1.13,7]decane; (4s)-N-(6-phenylpyridin-3-yl)-1-azatricyclo[3.3.1.13,7]decan-4-amine; (4s)-N-[5-(3-methylphenyl)-pyridin-3-yl]-1-azatricyclo[3.3.1.13,7]decan-4-amine; (4s)-N-[5-(3-chlorophenyl)-pyridin-3-yl]-1-azatricyclo[3.3.1.13,7]decan-4-amine; (4s)-4 N-[5-(3-chlorophenylphen-3-yl)-pyridin-3-yl]-1-azatricyclo[3.3.1.13,7]decan-4-amine; (4s)-4-{ [5-(4-chlorophenyl)pyridin-3-yl]oxy} -1-azatricyclo[3.3.1.13,7]decane; 5-{ 5-[(4s)-1-azatricyclo[3.3.1.13,7]dec-4-yloxy]pyridin-2-yl} -1,3-dihydro-2H-indol-2-one; 6-[(4s)-1-azatricyclo[3.3.1.13,7]dec-4-yloxy]-N-pyridin-4-ylpyridine-2-carboxamide; (4r)-4-[(6-phenylpyrazin-2-yl)oxy]-1-azatricyclo[3.3.1.13,7]decane; 2-[(4s)-1-azatricyclo[3.3.1.13,7]dec-4-yloxy]-N-pyridin-4-yl-1,3-thiazole-4-carboxamide; 2-[(4s)-1-azatricyclo[3.3.1.13,7]dec-4-yloxy]-N-(4-chlorophenyl)-1,3-oxazole-4-carboxamide; 2-[(4s)-1-azatricyclo[3.3.1.13,7]dec-4-yloxy]-N-phenyl-1,3-oxazole-4-carboxamide; or (4s)-5-4-[2-(1-azatricyclo[3.3.1.13,7]decan-1-oxide-yloxy)thiazol-5-yl]-indolin-2-one. Also disclosed are compositions comprising the compounds and uses thereof as nicotinic acetylcholine receptor ligands, useful in the treatment of conditions or disorders such as attention deficit disorder, attention deficit hyperactivity disorder (ADHD), Alzheimer’s disease, mild cognitive impairment, schizophrenia, age-associated memory impairment (AAMI), senile dementia, AIDS dementia, Pick’s disease, dementia associated with Lewy bodies, dementia associated with Down’s syndrome, amyotrophic lateral sclerosis, Huntington’s disease, smoking cessation, is nicotinic withdrawal syndrome, schizoaffective disorder, bipolar and manic disorders, diminished CNS function associated with traumatic brain injury, acute pain, post-surgical pain, chronic pain, inflammatory pain, and neuropathic pain.
Patent NZ-701890-A (NZ)
Title: Direct volume-controlling device (dvcd) for reciprocating positive-displacement pumps
Inventor: ELLIOTT ANDREW C
IPC: F16K31/363
Filed: 2013-04-26
Abstract: A volume control device having a housing with an inlet passage, an outlet passage, and an internal chamber communicating with the inlet and outlet passages. An accumulator is movably positioned within the internal chamber and substantially conforms with walls of the internal chamber, the accumulator including an internal passage allowing fluid flow therethrough. An one-way valve is positioned in the internal passage of the accumulator where the valve is biased in a closed position and an adjustable seat is positioned within the housing internal chamber between the accumulator and the housing outlet passage. A positioning mechanism engages the housing and adjustable seat whereby the position of the adjustable seat within the housing internal chamber may be adjustably fixed. Fluid driven into the inlet by a positive stroke of a reciprocating pump will displace the accumulator until the accumulator engages the adjustable seat. Thereafter, additional fluid entering the inlet will open the one-way valve and allow fluid to exit though the outlet until a negative stroke of the reciprocating pump allows the one-way valve to close, draws fluid out of the volume control device, and returns the accumulator to its starting position.
Patent NZ-702404-A (NZ)
Title: High efficient night cover
Inventor: NGUYEN KEN
IPC: A47F3/04
Filed: 2014-06-03
Abstract: A night cover assembly for a refrigerated merchandise display (10), which is positionable to substantially enclose a product display area, is disclosed. The night cover assembly comprises a housing (see 102, figure 3) attachable to the refrigerated merchandise display and a pull-down night cover (62) coupled to the housing. The pull-down night cover has a stowed position in the housing and is movable relative to the housing to a deployed position to extend across an access opening of the product display area. The pull-down night cover includes an open section defined by first openings and second openings that are smaller than the first openings, (82) configured to permit ambient airflow (86) through the night cover.
Patent NZ-716151-A (NZ)
Title: Novel complexes of agomelatine and sulphonic acids, method for preparing same and the pharmaceutical compositions that contain them
Inventor: LYNCH MICHAEL
IPC: A61P15/06
Filed: 2014-07-28
Abstract: Complexes of agomelatine and sulphonic acids of formula (I) for use as melatoninergic and 5-HT2C drugs in the treatment of depression, sexual function disorders and sleep disorders, among others.
Patent NZ-718459-A (NZ)
Title: Mold ripened cheese and preparation method thereof
Inventor: HOU JIANPING
IPC: A23C19/032
Filed: 2014-08-14
Abstract: A method for preparing mold ripened cheese, comprising the following steps: (1) sterilizing raw milk and cooling to obtain treated milk; inoculating the treated milk with penicillium camemberti, monascus sp. and lactic acid bacteria leavening agent, fermenting until the pH value is 5.8 to 6.5, and adding chymosin to obtain curded milk; (2) placing the curded milk into a mold for molding so as to obtain a curd block; (3) brine salting or dry salt coating the curd block to ripen the curd block; the ripening method being: ripening at 20°C-30°C for 2-15 days, ripening at 12°C-20°C for 2-15 days, and ripening at 4°C-15°C for 10-45 days.
Patent NZ-730540-A (NZ)
Title: Bottom-gusseted package and heat-sealing method
Inventor: YEAGER JAMES
IPC: B31B155/00
Filed: 2015-09-08
Abstract: A bottom-gusseted package comprises a package body, and a bottom gusset positioned transversely of a longitudinal axis of the package body, Formation of the bottom-gusseted package is effected by positioning individual sleeves transversely of the longitudinal axis of a flexible web which forms the package body. During package formation, the flexible web is cut to form individual packages, with each individual sleeve positioned to form a bottom gusset in a respective package. Cooperating heat- sealing jaws, including cooperating U-shaped sealing surfaces, act to integrate and seal each individual sleeve with the flexible web to form the bottom gusset of each package, with the heat-sealing jaws preferably configured to include cooperating top sealing surfaces for simultaneously forming a top seal in an adjacent one of the packages. The pair of side sealing surfaces of each one of the sealing jaws includes sealing surfaces for heat-sealing the front and rear package panels to each other above the respective one of the individual sleeves forming the bottom gusset. The method allows forming a package of any selected height.
Patent NZ-744400-A (NZ)
Title: Eye image collection, selection, and combination
Inventor: KAEHLER ADRIAN
IPC: H04N5/247
Filed: 2017-01-17
Abstract: In some cases, images of the eyes produced by a camera used for eye tracking can be some distance from the eyes of a user. As a result, the images of the eyes produced by the camera can poor resolution. With the techniques disclosed herein, eye image processing can be used to substantially identify a pointing direction of the eye and additionally or alternatively enhance the resolution of eye image for iris code generation. Systems and methods for eye image set selection, eye image collection, and eye image combination are described. Embodiments of the systems and methods for eye image collection can include displaying a graphic along a path connecting a plurality of eye pose regions. Eye images at a plurality of locations along the path can be obtained, and an iris code can be generated based at least partly on at least some of the obtained eye images.
Patent NZ-747061-A (NZ)
Title: Prodrug of amino acid derivative
Inventor: MASUDA SEIJI
IPC: C07C229/50
Filed: 2017-04-18
Abstract: Provided is an amino acid derivative prodrug represented by general formula (I-A) that is a prodrug form of an amino acid derivative which is a group 2 metabotropic glutamate receptor antagonist, or a pharmaceutically acceptable salt thereof. More specifically, provided is an amino acid derivative prodrug represented by general formula (I-A) that is a preventive or therapeutic drug for mood disorders (including depression and bipolar disorder), anxiety disorder, cognitive disorders, developmental disorders, Alzheimer’s disease, Parkinson’s disease, movement disorders associated with muscular rigidity, sleep disorders, Huntington’s chorea, eating disorders, drug dependence, epilepsy, brain infarction, cerebral ischemia, cerebral insufficiency, cerebral edema, spinal cord disorders, head trauma, inflammation and immune- related diseases, and so on.